Classification
- Anatomical main groupBBlood and blood-forming organs
- Therapeutic subgroupB01
- Pharmacological subgroupB01A
- Chemical subgroupB01AD
- Chemical substanceB01AD07Reteplase
Where it is registered
Each register and historical list with its number of registrations and a few of them.
European Union
EMA · 2 registrations
Canada
Health Canada · 1 registration
Spain
AEMPS · 1 registration
Croatia
HALMED · 1 registration
United States
At a glance
- ATC code
- B01AD07
- ATC group
- Blood and blood-forming organs
- Registers
- 5
- Historical lists
- 1
- Registrations
- 7
- With their own page
- 2
- Companies
- 4
All medicines with Reteplase
Human medicines from every register that match Reteplase by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
7 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Retavase | United States | 18.8MG/VIAL | vial | Marketed | Ekr Therap |
| Rapilysin | Croatia | Authorised | |||
| Retavase | Canada | 10.4 UNIT / VIAL | Powder For Solution | Cancelled | Ekr Therapeutics INC |
| Ecokinase | European Union | Withdrawn | Roche Registration Ltd. | ||
| Rapilysin | European Union | Withdrawn | Actavis Group PTC ehf | ||
| Rapilysin 10 U, Polvo y Disolvente Para Solucion InyectableCombination | Spain | 10 U + 10 ml | polvo y disolvente para solución inyectable | Withdrawn | Actavis Group Ptc Ehf. |
| Rapilysin 10 U | Romania | 10 U | pulb. + solv. pt. sol. inj. | Status unknown | Actavis Group PTC Ehf. |